COVID-19: PCR screening of asymptomatic health-care workers at London hospital
Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 2020-06-30
Type
Journal Article
Author
Thomas A. Treibel
Author
Charlotte Manisty
Author
Maudrian Burton
Author
Áine McKnight
Author
Jonathan Lambourne
Author
João B. Augusto
Author
Xosé Couto-Parada
Author
Teresa Cutino-Moguel
Author
Mahdad Noursadeghi
Author
James C. Moon
URL
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31100-4/abstract
Series
The Lancet Correspondence
Volume
395
Issue
10237
Pages
1608-1610
Publication
The Lancet
ISSN
0140-6736, 1474-547X
Date
08/05/2020
Extra
Publisher: Elsevier
PMID: 32401714
Journal Abbr
The Lancet
DOI
10.1016/S0140-6736(20)31100-4
Accessed
2020-06-30 17:32:43
Library Catalog
www.thelancet.com
Language
English
Abstract
The exponential growth in coronavirus disease 2019 (COVID-19) caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) across the UK has been successfully
reversed by social distancing and lockdown.1 RNA testing for prevalent infection is
a key part of the exit strategy, but the role of testing for asymptomatic infection
remains unclear.2 Understanding the determinants of asymptomatic or pauci-symptomatic
infection will provide new opportunities for personalised risk stratification and
reveal much-needed correlates of protective immunity, whether induced by vaccination
or natural exposure.
Short Title
COVID-19